Trial record 21 of 115 for: "Viral Infectious Disease" | "Ledipasvir"
Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02226549|
Recruitment Status : Completed
First Posted : August 27, 2014
Results First Posted : March 4, 2016
Last Update Posted : November 16, 2018
Information provided by (Responsible Party):
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Hepatitis C Virus Infection
|Recruitment Details||Participants were enrolled at 1 study site in the United States. The first participant was screened on 24 July 2014. The last study visit occurred on 06 February 2015.|
|Pre-assignment Details||72 participants were screened.|
There were no limitations affecting the analysis or results.